CIP
MJN

Champlain Investment Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Champlain Investment Partners’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-795,640
Closed -$70.9M – 125
2017
Q1 		$70.9M Sell
795,640
-19,950
-2% -$1.64M 0.93% 43
2016
Q4 		$57.7M Buy
815,590
+189,985
+30% +$14.2M 0.8% 44
2016
Q3 		$49.4M Buy
625,605
+128,420
+26% +$11M 0.75% 56
2016
Q2 		$45.1M Sell
497,185
-56,220
-10% -$4.76M 0.78% 52
2016
Q1 		$47M Buy
553,405
+6,575
+1% +$489K 0.85% 45
2015
Q4 		$43.2M Buy
546,830
+293,230
+116% +$23.1M 0.74% 58
2015
Q3 		$17.9M Buy
+253,600
New +$20.9M 0.31% 107
2014
Q3 		– Sell
-218,365
Closed -$20.3M – 146
2014
Q2 		$20.3M Buy
218,365
+8,075
+4% +$706K 0.33% 112
2014
Q1 		$17.5M Buy
210,290
+20,155
+11% +$1.63M 0.3% 116
2013
Q4 		$15.9M Buy
190,135
+180
+0.1% +$14.7K 0.28% 115
2013
Q3 		$14.1M Buy
189,955
+11,435
+6% +$857K 0.27% 116
2013
Q2 		$14.1M Buy
+178,520
New +$14.3M 0.29% 121

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Champlain Investment Partners's MJN Position: Q2 2017 in Review

Champlain Investment Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 795,640 shares — an estimated $70.9M sold.

Champlain Investment Partners first reported a position in MJN in Q2 2013 and held it in 12 quarters. The position peaked at $70.9M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Champlain Investment Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Champlain Investment Partners sold 795,640 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $70.9M.
  • Champlain Investment Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 12 quarters.
  • Champlain Investment Partners's Mead Johnson Nutrition Company position peaked at $70.9M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Champlain Investment Partners's 13F filing for Q2 2017, filed 11 Aug 2017.